Stock page

Nipro Corp (NPRRF)

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Quote snapshot

$9.96
Daily change: —
ExchangeOTCPK
Updated2026-05-09T03:56:30.679931Z

Price chart

Price history

Name
Revenue
Cost Of Goods Sold
Gross Profit
Gross Margin %
Research Development
Selling General Admin Expense
Depreciation Depletion Amortization
Other Operating Expense
Total Operating Expense
Operating Income
Operating Margin
Interest Income
Interest Expense
Other Income Expense
Other Income Minority Interest
Other Net Income Loss
Ebit
Ebitda
Ebitda Margin
Pretax Income
Tax Provision
Tax Rate
Net Income Continuing Operations
Net Income Discontinued Operations
Net Income
Net Income Including Noncontrolling Interests
Is Preferred Dividends
Shares Outstanding
Eps Basic
Eps Diluted
Net Margin

SEC filings

Latest 10-K filing table

Date Form Accession Link